Executing a successful clinical trial requires seamless communication
and coordination among many stakeholders–study sponsors, contract
research organizations, academic research organizations, site management
organizations, patient recruiters, clinical investigators and patients.
Research shows that there is much room for improvement. The average
Phase 1, 2, and 3 trials exceed their timelines by 20%. Delays in the
clinical trial process cost pharma companies hundreds of thousands—even
millions—in sales. Today, companies also encounter formidable challenges
in the clinical development process, including the FDA’s increased
involvement.
Streamlining Clinical Trials is the authoritative tool for clinical
operations teams to accelerate their trials. This comprehensive guide
delves into the latest industry trends and strategies for elevating
efficiency. It focuses on resource allocation, performance
measurement, continuous process improvement, patient and investigator
recruitment and adaptive trial designs. Through extensive
benchmarking data, real-company case studies and interviews with
industry experts, the report shows how companies are moving their
product candidates through development faster and more efficiently.
Use the report to:
- Benchmark your clinical operations against leading companies
- Clarify performance objectives
- Identify and eliminate common trial bottlenecks
- Drive successful patient recruitment campaigns
- Plan study design and protocol effectively
- Discover and apply innovative patient and investigator retention
strategies
- Weigh the pros and cons of adaptive trial designs versus
traditional trials

|
More Cutting Edge
Information Reports: |
|
 |
 |
 |